- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Illumina Inc (ILMN)
"Illumina Inc stock price live, this page displays NASDAQ ILMN stock exchange data. View the ILMN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Illumina Inc real time stock price chart below.
What Is the Illumina Inc Stock Price Today?
The Illumina Inc stock price today is 137.37.
What Is the Stock Symbol for Illumina Inc?
The stock symbol for Illumina Inc is ""ILMN.""
What Stock Exchange Does Illumina Inc Trade On?
Illumina Inc is listed and trades on the NASDAQ stock exchange.
Is Illumina Inc a Good Stock to Buy?
Determining whether Illumina Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ILMN quote. (ISIN: US4523271090)"
What Is the Illumina Inc Stock Price Today?
The Illumina Inc stock price today is 137.37.
What Is the Stock Symbol for Illumina Inc?
The stock symbol for Illumina Inc is ""ILMN.""
What Stock Exchange Does Illumina Inc Trade On?
Illumina Inc is listed and trades on the NASDAQ stock exchange.
Is Illumina Inc a Good Stock to Buy?
Determining whether Illumina Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ILMN quote. (ISIN: US4523271090)"
137.37
+1.18(+0.87%)
Closed
Pre Market
136.63-0.74(-0.54%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
131.75
138.00
52 wk Range
97.27
156.66
ILMN Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
131.75138.00
52 wk Range
97.27156.66
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ILMN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
162.80
Upside
+18.51%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a poor free cash flow yield
- Illumina stock falls on 2025 outlook miss
- Investing.com
- Illumina stock falls on 2025 outlook miss
- Investing.com
Illumina Inc Company Profile
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
Illumina Inc SWOT Analysis
Genomic Dominance | Illumina maintains leadership in next-generation sequencing despite pricing pressures, with strong consumables growth offsetting instrument sales weakness |
NovaSeq X Revolution | Explore Illumina's strategic transition to NovaSeq X, promising threefold cost reduction in sequencing and potential market expansion |
Competitive Landscape | Learn how Illumina's focus on total workflow cost and multi-omics applications aims to fend off emerging competition in long-read sequencing |
Financial Outlook | Analyst price targets range from $110 to $254, with Illumina targeting high single-digit growth and double-digit EPS CAGR through 2027 |
Illumina Inc Earnings Call Summary for Q3/2024
- Q3 revenue down 2% YoY to $1.1B; non-GAAP operating margin at 22.6%; EPS at $1.14
- Sequencing consumables up 7%, instruments down 42%; 58 NovaSeq X Plus placed, total 527
- 2023 revenue forecast: -3% YoY; 2024 guidance: operating margin 21-21.5%, EPS $4.05-$4.15
- Acquired Fluent BioSciences; $939M cash on hand; issued $500M debt at lower coupon
- Targeting high single-digit revenue growth by 2027; focus on operational improvements
Last Updated: 11/05/2024, 04:22 PM
Read Full TranscriptCompare ILMN to Peers and Sector
Metrics to compare | ILMN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipILMNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −10.5x | −0.6x | |
PEG Ratio | 0.35 | −0.07 | 0.00 | |
Price/Book | 0.0x | 1.7x | 2.6x | |
Price / LTM Sales | 0.0x | 3.5x | 3.1x | |
Upside (Analyst Target) | 16.2% | 111.2% | 51.5% | |
Fair Value Upside | Unlock | 2.9% | 8.4% | Unlock |
Analyst Ratings
12 Buy
12 Hold
1 Sell
Ratings:
25 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 162.80
(+18.51% Upside)
Earnings
Latest Release
Nov 04, 2024
EPS / Forecast
1.14 / 0.88
Revenue / Forecast
1.08B / 1.08B
People Also Watch
FAQ
What Is the Illumina (ILMN) Stock Price Today?
The Illumina stock price today is 137.37
What Stock Exchange Does Illumina Trade On?
Illumina is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Illumina?
The stock symbol for Illumina is "ILMN."
What Is the Illumina Market Cap?
As of today, Illumina market cap is 21.89B.
What is Illumina Earnings Per Share?
The Illumina EPS is -8.15.
What Is the Next Illumina Earnings Date?
Illumina will release its next earnings report on Feb 05, 2025.
From a Technical Analysis Perspective, Is ILMN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.